NCT05011708View on ClinicalTrials.gov

I-DROP MGD Symptomatic Relief and Tear Film Stability

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

December 15, 2021

Study Completion Date

January 12, 2022

Conditions
Dry Eye
Interventions
DEVICE

I-DROP MGD

I-DROP MGD are eye drop produced by I-MED PHARMA for the management of moderate to severe Dry Eye Disease.

DEVICE

Thealoz Duo

I-DROP MGD are eye drop produced by Laboratoires Thea for the management of Dry Eye Disease.

Trial Locations (2)

N2L 3G1

Centre for Ocular Research & Education, Toronto

Centre for Ocular Research & Education (CORE), Waterloo

Sponsors

Lead Sponsor

I-MED Pharma
All Listed Sponsors
collaborator

University of Waterloo

OTHER

lead

I-MED Pharma

INDUSTRY